期刊文献+

帕金森病实验动物模型研究进展 被引量:11

下载PDF
导出
摘要 帕金森病(PD)是一种进行性神经退行性病变,其主要特征为黑质纹状体通路的多巴胺能神经元发生变性坏死。尽管以改善PD症状为主的现代医疗方法取得了很大进步,但大多数患者最终还是走向衰弱和残疾。因此,为了更好地了解PD的病理机制和寻求更有效的治疗方法,PD相关动物模型的制作很重要。此文综述了目前常见的PD动物模型并探讨了其各自的应用价值。
作者 王涛 左萍萍
出处 《中国神经免疫学和神经病学杂志》 CAS 2008年第6期455-457,共3页 Chinese Journal of Neuroimmunology and Neurology
  • 相关文献

参考文献10

  • 1Hallett PJ, Brotchie JM. Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia[J]. Mov Disord, 2007,22 (1): 28-40.
  • 2Emborg ME. Evaluation of animal models of Parkinson's disease for neuroprotective strategies [J]. J Neurosci Methods, 2004,139 (2):121-143.
  • 3Reksidler AB, Lima MM, Zanata SM, et al. The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats[J]. Eur J Pharmacol,2007,560(2-3):163-175.
  • 4Richardson JR, Quan Y, Sherer TB,et al. Paraquat neurotoxicity is distinct from that of MPTP and rote none[J]. Toxicol Sci, 2005, 8(1) :193-201.
  • 5Li X, Matsumoto K, Murakami Y,et al. Neuroprotective effects of Polygonum muhiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice[J]. Pharmacol Biochem Behav, 2005, 82(2):345-352.
  • 6Hunter RL, Dragicevic N, Seifert K,et al. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system[J]. J Neurochem, 2007,100(5) : 1375-1386.
  • 7Goldberg MS, Fleming SM, Palacino JJ,et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons[J]. J Biol Chem, 2003, 278(44) :43628-43635.
  • 8Kim RH, Smith PD, Aleyasin H,et al. Hypersensitivity of DJ-1-defieient mice to 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyrindine (MPTP) and oxidative stress [J]. Proc Natl Acad Sci U S A, 2005, 102(14) :5215- 5220.
  • 9Battaglia G, Farrace MG, Mastroberardino PG,et al. Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex Ⅰ affecting neuronal vulnerability in experimental models of extrapyramidal disorders [J]. J Neurochem, 2007, 100 (1) : 36- 49.
  • 10McNaught KS, PerI DP, Brownell AL, et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease[J]. Ann Neurol, 2004,56(1) :149-162.

同被引文献117

  • 1焦金菊,姜恩魁,高东明,常志杰,庄晓燕,岳春良,刘颖.微量注射6-OHDA损毁大鼠黑质对丘脑底核神经元电活动影响的研究[J].数理医药学杂志,2004,17(6):498-499. 被引量:2
  • 2李宗明,李鸿勋.黑质在痛觉调制中的作用[J].生理科学进展,1994,25(3):228-232. 被引量:1
  • 3王莉莉,徐胜利,陈彪.表没食子儿茶素没食子酸酯对6-OHDA导致的多巴胺能神经细胞损伤的保护作用[J].中国行为医学科学,2007,16(4):311-314. 被引量:2
  • 4Von Bohlen, Halbach O. ModeLing neurodegenerative diseases in vivo review[J]. Neurodegener Dis, 2005, 2(6):313-320.
  • 5Cohen G, Heikkila RE. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6 hydroxydopamine, dialurie acid, and related cytotoxic agents[J]. J Biol Chem, 1974, 249:2447-2452.
  • 6Lee CS, Sauer H, Bjorklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopaminein the rat[J]. Neuroscience, 1996, 72:641-653.
  • 7Ji C, Aisa HA, Yang N, et al. Gossypium herbaceam extracts inhibited NF kappaB activation to attenuate spatial memory impairment and hippoeampal neurodegeneration induced by amyloid beta in rats [J]. J AlzheimersDis, 2008, 14:271-283.
  • 8Glinka Y, Gassen M, Youdim MB. Mechanism of 6-hydroxydopam ine neurotoxicity[J]. J Neural Transm Suppl, 1997, 50:55-66.
  • 9Zhao DL, Zou LB, Lin S, et al. Anti-apoptotic effect of eseulin on dopamine-indueed cytotoxicity in the human neuroblastoma SH-SY5Y cell line[J]. Neuropharmacology, 2007, 53:724-732.
  • 10Guo S, Yan J, Yang T, et al. Protective effects of green tea poly phenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway[J]. Biol Psychiatry, 2007, 62:1353-1362.

引证文献11

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部